koryu

editas medicine crispr/cas9 investment

Largo
koryu Actualizado   
NASDAQ:EDIT   Editas Medicine, Inc.
12
I enter long as long term investment in CRISPR/Cas9 technology.

There is still a patent battle going on, thats why there is the big dump in the chart.

Buying here feels like catching the knife, so buying slowly over time.


Operación activa:
nice start. also watching NTLA
Comentarios:
was lucky and got in at 13.40$

There was a bullish divergence on daily rsi. Now watching carefully if it is an additional inv h+s forming. Really like this stock. Ready to increase position if bottom is confirmed.

Comentarios:
increasing position in this dip
Comentarios:
pitchfork scenario
Comentarios:
adjusted pitchfork and channel, fits really good! would be amazing bull market (must break out the channel!) definitly watch this
Comentarios:
break out channel and horizontal resistance! <3
Comentarios:
EW
Comentarios:
bounced on the potential pitchfork and formed a weekly hammer candle which tested the long term downtrend in bullish manner
Comentarios:
HODL the double up :D

Exención de responsabilidad

La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.